Tenaya Therapeutics, Inc. (TNYA)
USD 1.23
(-12.77%)
USD 1.23
(-12.77%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -102.07 Million | -104.42 Million | -60.81 Million | -35.44 Million | -24.09 Million |
| Net Income | -124.08 Million | -123.66 Million | -72.72 Million | -38.39 Million | -26.23 Million |
| Depreciation & Amortization | 8.68 Million | 6.46 Million | 2.96 Million | 2.48 Million | 1.98 Million |
| Deferred income taxes | 3.28 Million | - | 192 Thousand | 33 Thousand | -82 Thousand |
| Stock-based compensation | 15.3 Million | 11.46 Million | 2.95 Million | 741 Thousand | 414 Thousand |
| Change in working capital | -5.64 Million | -849 Thousand | 4.74 Million | -234 Thousand | -250 Thousand |
| Other non-cash items | 382 Thousand | 2.15 Million | 1.06 Million | -75 Thousand | 64 Thousand |
| Investing Cash Flow | 48.71 Million | 83.65 Million | -238.56 Million | -7.01 Million | -5.58 Million |
| Investments in PPE | -1.23 Million | -20.63 Million | -25.12 Million | -9.76 Million | -2.92 Million |
| Acquisitions | - | - | - | - | 2657.00 |
| Investment purchases | -56.64 Million | -140.47 Million | -213.44 Million | - | -12.65 Million |
| Sales/Maturities of investments | 106.62 Million | 244.75 Million | - | 2.75 Million | 10 Million |
| Other Investing Activities | -25 Thousand | 8000.00 | -213.44 Thousand | 2753.00 | -2657.00 |
| Financing Cash Flow | 4.04 Million | 77.76 Million | 208.97 Million | 147.26 Million | 30.51 Million |
| Debt repayment | - | - | - | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | -13 Thousand | -1000.00 | -3000.00 |
| Common Stock Issuance | 4.55 Million | 77.38 Million | 188.54 Million | 147.26 Million | 30.51 Million |
| Other Financing Activities | -501 Thousand | 380 Thousand | 20.44 Million | 147.26 Thousand | 30.51 Thousand |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | -3.28 Million | 1.66 Million | 8.6 Million | 142 Thousand | 397 Thousand |
| Inventory | - | - | - | - | - |
| Other working capital | -2.36 Million | -2.5 Million | -3.85 Million | -376 Thousand | -647 Thousand |
| Cash at beginning of period | 95.27 Million | 38.67 Million | 129.08 Million | 24.27 Million | 23.43 Million |
| Cash at end of period | 45.68 Million | 95.67 Million | 38.67 Million | 129.08 Million | 24.27 Million |
| Capital Expenditure | -1.23 Million | -20.63 Million | -25.12 Million | -9.76 Million | -2.92 Million |
| Effect of forex changes on cash | -283 Thousand | - | - | - | - |
| Net cash flow / Change in cash | -49.59 Million | 56.99 Million | -90.4 Million | 104.81 Million | 832 Thousand |
| Free Cash Flow | -103.31 Million | -125.05 Million | -85.93 Million | -45.21 Million | -27.02 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -29.43 Million | -32.22 Million | -29.93 Million | -124.08 Million | -29.14 Million | -33.26 Million |
| Depreciation & Amortization | 2.12 Million | 2.15 Million | 2.98 Million | 8.68 Million | 2.18 Million | 2.19 Million |
| Deferred income taxes | - | - | -10.22 Million | 3.28 Million | -315 Thousand | -489 Thousand |
| Stock-based compensation | 4.61 Million | 4.22 Million | 3.94 Million | 15.3 Million | 4.01 Million | 3.83 Million |
| Change in working capital | -1.93 Million | -3.63 Million | -671 Thousand | -5.64 Million | -1.22 Million | 683 Thousand |
| Other non-cash items | 12.3 Million | 8.09 Million | 11.97 Million | 382 Thousand | 848 Thousand | 829 Thousand |
| Investing Cash Flow | 21.61 Million | -4.48 Million | -14.91 Million | 48.71 Million | 30.48 Million | 25.08 Million |
| Investments in PPE | -73 Thousand | -564 Thousand | -394 Thousand | -1.23 Million | -8000.00 | -208 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -10.8 Million | -23.64 Million | -15.64 Million | -56.64 Million | - | -15.2 Million |
| Sales/Maturities of investments | 32.49 Million | 19.71 Million | 1.13 Million | 106.62 Million | 30.5 Million | 40.48 Million |
| Other Investing Activities | 4000.00 | 1000.00 | -18 Thousand | -25 Thousand | -4000.00 | 9000.00 |
| Financing Cash Flow | 570 Thousand | 46.77 Million | 371 Thousand | 4.04 Million | - | 4.17 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 570 Thousand | 46.77 Million | 371 Thousand | 4.55 Million | - | 4.17 Million |
| Other Financing Activities | 570 Thousand | 9000.00 | 371.00 | -501 Thousand | - | 4179.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -2.43 Million | 1.27 Million | -305 Thousand | -3.28 Million | -2.75 Million | 1.1 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 493 Thousand | -4.91 Million | -366 Thousand | -2.36 Million | 1.53 Million | -418 Thousand |
| Cash at beginning of period | 59.3 Million | 45.68 Million | 82.15 Million | 95.27 Million | 75.98 Million | 72.94 Million |
| Cash at end of period | 58.13 Million | 59.3 Million | 45.68 Million | 45.68 Million | 82.83 Million | 75.98 Million |
| Capital Expenditure | -73 Thousand | -564 Thousand | -394 Thousand | -1.23 Million | -8000.00 | -208 Thousand |
| Effect of forex changes on cash | - | - | - | -283 Thousand | - | - |
| Net cash flow / Change in cash | -1.16 Million | 13.62 Million | -36.47 Million | -49.59 Million | 6.85 Million | 3.04 Million |
| Free Cash Flow | -23.69 Million | -29.22 Million | -22.31 Million | -103.31 Million | -23.64 Million | -26.42 Million |
600757
5283
0008
4631
9548
ARE